Stocks › INSM

INSMED Inc

INSM·Nasdaq·United States United States·USD
$141.33
-3.13 (-2.17%)
Close · Nov 20, 2026 · Close Prices from Tiingo.com
INSM
INSMED Inc · Nasdaq
Nasdaq 100S&P 500
Filings
Default90D1Y5YALL
INSMS&P 500 (rebased)
Congress BuyCongress SellInsider BuyInsider SellForm 1448-K ResultsLobbying
Loading price history…
Daily closes, adjusted for splits and dividends · Close Prices from Tiingo.comHover a marker, every one is a filing · move across the line for the crosshair

Congressional Trades

Recent trades of INSM by members of U.S. Congress · 10 on record · 1 in the last 12 months
All congressional trades →
PoliticianStockTypeFiledTraded
Josh GottheimerJosh GottheimerHouse · D · NJ INSMINSMED Inc · Stock Sale
$1,001 - $15,000
Jul 7, 2026 Jun 10, 2026 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA INSMINSMED Inc · Stock Sale
$1,001 - $15,000
Nov 18, 2025 Oct 3, 2025 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA INSMINSMED Inc · Stock Sale
$1,001 - $15,000
Oct 10, 2025 Sep 22, 2025 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA INSMINSMED Inc · Stock Sale
$1,001 - $15,000
Sep 12, 2025 Aug 8, 2025 Filing ↗
Gilbert Ray Cisneros, Jr.Gilbert Ray Cisneros, Jr.House · D · CA INSMINSMED Inc · Stock Sale
$1,001 - $15,000
Aug 14, 2025 Jul 7, 2025 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ INSMINSMED Inc · Stock Purchase
$1,001 - $15,000
Jul 16, 2025 Jun 16, 2025 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ INSMINSMED Inc · Stock Sale
$1,001 - $15,000
May 14, 2025 Apr 9, 2025 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ INSMINSMED Inc · Stock Sale
$1,001 - $15,000
Jul 9, 2024 Jun 21, 2024 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ INSMINSMED Inc · Stock Sale
$1,001 - $15,000
Jun 8, 2024 May 28, 2024 Filing ↗
Josh GottheimerJosh GottheimerHouse · D · NJ INSMINSMED Inc · Stock Purchase
$1,001 - $15,000
Jan 13, 2023 Dec 6, 2022 Filing ↗

Whale Activity

Position changes in INSM reported for 2026-09-30 by 787 institutional filers
Increased: 264New: 120Held: 75Decreased: 212Closed: 81No prior filing: 35
  • Increased264
  • New120
  • Held75
  • Decreased212
  • Closed81
  • No prior filing35
FilerSharesValueChange
BlackRock, Inc.15.9M$1.82Bincreased
FMR LLC15.5M$1.77Bdecreased
VANGUARD PORTFOLIO MANAGEMENT LLC10.5M$1.20Bincreased
VANGUARD CAPITAL MANAGEMENT LLC9.8M$1.12Bincreased
Capital International Investors9.4M$1.07Bincreased
BAKER BROS. ADVISORS LP8.8M$1.00Bheld
JPMORGAN CHASE & CO8.2M$953.2Mdecreased
Orbis Allan Gray Ltd6.7M$768.6Mincreased
AMERIPRISE FINANCIAL INC6.3M$713.5M—
STATE STREET CORP6.2M$703.4Mincreased
Artisan Partners Limited Partnership5.6M$636.7Mincreased
AQR CAPITAL MANAGEMENT LLC5.2M$594.6Mincreased

Every 13F filer's complete reported book, every quarter since 2013-06-30. 13F itself excludes short positions, cash and most options.

Insider Trading

Net shares bought (+) or sold (−) on the open market by INSM insiders, by quarter · Form 4
-1.0M-500.0K0500.0K1.0M2025 Q1: -684.2K2025 Q12025 Q2: -618.2K2025 Q22025 Q3: -506.4K2025 Q32025 Q4: -228.6K2025 Q42026 Q1: -274.4K2026 Q12026 Q2: -263.3K2026 Q22026 Q3: -330.7K2026 Q32026 Q4: -101.1K2026 Q4

Recent Insider Transactions

1,340 transactions on record · newest first
All insider activity →
InsiderTypeSharesPriceValueDate
Schaeffer Orlov S NicoleChief People Strategy Officer Sale −90.3K $145.06 $13.1M Nov 19, 2026 Form 4 ↗
Schaeffer Orlov S NicoleChief People Strategy Officer Sale −8,539 $146.76 $1.3M Nov 19, 2026 Form 4 ↗
Schaeffer Orlov S NicoleChief People Strategy Officer Sale −2,262 $147.50 $334K Nov 19, 2026 Form 4 ↗
Brennan David RDirector Sale −25.0K $124.00 $3.1M Sep 9, 2026 Form 4 ↗
SHAROKY MELVIN MDDirector Sale −5,000 $127.53 $638K Aug 17, 2026 Form 4 ↗
Adsett RogerChief Operating Officer Sale −239.8K $133.27 $32.0M Aug 10, 2026 Form 4 ↗
Adsett RogerChief Operating Officer Option exercise +81.0K $30.46 $2.5M Aug 10, 2026 Form 4 ↗
Adsett RogerChief Operating Officer Option exercise +76.6K $17.16 $1.3M Aug 10, 2026 Form 4 ↗
Adsett RogerChief Operating Officer Option exercise +82.3K $13.67 $1.1M Aug 10, 2026 Form 4 ↗
Flammer Martina M.D.Chief Medical Officer Sale −18.3K $129.40 $2.4M Aug 6, 2026 Form 4 ↗
Flammer Martina M.D.Chief Medical Officer Sale −8,895 $127.00 $1.1M Aug 6, 2026 Form 4 ↗
Flammer Martina M.D.Chief Medical Officer Option exercise +8,895 $25.83 $230K Aug 6, 2026 Form 4 ↗
Flammer Martina M.D.Chief Medical Officer Option exercise +18.3K $18.95 $346K Aug 6, 2026 Form 4 ↗
Lewis WilliamChair and CEO · Director Sale −5,872 $106.43 $625K Jul 23, 2026 Form 4 ↗
Lewis WilliamChair and CEO · Director Sale −4,828 $105.62 $510K Jul 23, 2026 Form 4 ↗
Lewis WilliamChair and CEO · Director Option exercise +4,440 $17.16 $76K Jul 23, 2026 Form 4 ↗
Lewis WilliamChair and CEO · Director Option exercise +6,260 $30.46 $191K Jul 23, 2026 Form 4 ↗
Lewis WilliamChair and CEO · Director Sale −3,359 $118.52 $398K Jul 9, 2026 Form 4 ↗
Lewis WilliamChair and CEO · Director Sale −2,335 $117.62 $275K Jul 9, 2026 Form 4 ↗
Lewis WilliamChair and CEO · Director Sale −5,005 $116.55 $583K Jul 9, 2026 Form 4 ↗

Fund Holders

Mutual funds and ETFs holding INSM · SEC Form N-PORT
FundSharesValue% of fundAs of
Growth Fund of America6.8M$822.4M0.23%Aug 31, 2026
VANGUARD TOTAL STOCK MARKET INDEX FUND
VANGUARD INDEX FUNDS
6.9M$734.0M0.03%Jun 30, 2026
JPMorgan Large Cap Growth Fund
JPMorgan Trust II
2.8M$297.5M0.24%Jun 30, 2026
VANGUARD SMALL-CAP INDEX FUND
VANGUARD INDEX FUNDS
2.5M$265.1M0.14%Jun 30, 2026
VANGUARD EXTENDED MARKET INDEX FUND
VANGUARD INDEX FUNDS
2.5M$265.0M0.27%Jun 30, 2026
VANGUARD MID-CAP INDEX FUND
VANGUARD INDEX FUNDS
2.3M$250.4M0.11%Jun 30, 2026
Fidelity Advisor Growth Opportunities Fund
Fidelity Advisor Series I
1.7M$201.4M0.59%Aug 31, 2026
VANGUARD GROWTH INDEX FUND
VANGUARD INDEX FUNDS
1.8M$192.3M0.05%Jun 30, 2026
iShares Biotechnology ETF
iShares Trust
1.5M$162.2M1.78%Jun 30, 2026
JPMorgan Mid Cap Growth Fund
JPMorgan Trust II
1.4M$152.9M1.16%Jun 30, 2026

Mutual funds and ETFs whose N-PORT filings list INSM's shares (CUSIP 457669307), each fund at its latest report since Apr 21, 2026, largest positions first. Bonds, options and short positions are left out.

Activist & Passive Stakes

Schedule 13D / 13G beneficial-ownership filings
  • Darwin Global Master Fund, Ltd.SCHEDULE 13G/A · passive (13G) · 6.3M shares2.9%
    Aug 14, 2026 · ↗
  • Dr. Abhishek TrehanSCHEDULE 13G/A · passive (13G) · 6.4M shares3.0%
    Aug 14, 2026 · ↗
  • Darwin Global Management, Ltd.SCHEDULE 13G/A · passive (13G) · 6.4M shares3.0%
    Aug 14, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G/A · passive (13G) · 16.1M shares7.4%
    Aug 6, 2026 · ↗
  • FMR LLCSCHEDULE 13G/A · passive (13G) · 16.1M shares7.4%
    Aug 6, 2026 · ↗
  • JPMORGAN CHASE & CO.SCHEDULE 13G/A · passive (13G) · 10.4M shares4.7%
    Jul 22, 2026 · ↗
  • Darwin Global Master Fund, Ltd.SCHEDULE 13G/A · passive (13G) · 14.2M shares6.6%
    May 15, 2026 · ↗
  • Dr. Abhishek TrehanSCHEDULE 13G/A · passive (13G) · 16.8M shares7.8%
    May 15, 2026 · ↗
  • Darwin Global Management, Ltd.SCHEDULE 13G/A · passive (13G) · 16.8M shares7.8%
    May 15, 2026 · ↗
  • Abigail P. JohnsonSCHEDULE 13G · passive (13G) · 13.1M shares6.1%
    May 6, 2026 · ↗

Corporate Lobbying

Estimated quarterly lobbying spending reported under the LDA, filings naming insmed as client
$0$25K$50K$75K$100K2025 Q2: $10K2025 Q3: $10K2025 Q4: $10K20252026 Q1: $10K2026 Q2: $30K2026 Q3: $60K2026
  • LMH STRATEGIC SOLUTIONSINSMED INCORPORATED · 2026 Q3 · TRD$50K
    Filing ↗
  • JEFFREY J. KIMBELL & ASSOCIATES, INC.INSMED, INC. · 2026 Q3 · HCR, MMM$10K
    Filing ↗
  • JEFFREY J. KIMBELL & ASSOCIATES, INC.INSMED, INC. · 2026 Q2 · HCR, MMM$10K
    Filing ↗
  • LMH STRATEGIC SOLUTIONSINSMED INCORPORATED · 2026 Q2 · TRD$20K
    Filing ↗
  • LMH STRATEGIC SOLUTIONSINSMED INCORPORATED · 2026 Q2 · TRD—
    Filing ↗

Government Contracts

Federal awards to insmed · USAspending
$31KAwarded · 1 contract on record
  • Department of Veterans AffairsREZDIFFRA 80 MG$31K
    Jun 10, 2026 · ↗

U.S. Patents

Recent USPTO applications naming INSMED Inc

No USPTO patent applications found for INSMED Inc.

Annual Financials

From INSM's 10-K filings · XBRL
Fiscal yearFY2025FY2024FY2023FY2022FY2021
Revenue$606.4M$363.7M$305.2M$245.4M$188.5M
Operating income-$1.25B-$878.3M-$709.6M-$457.3M-$375.1M
Net income-$1.28B-$913.8M-$749.6M-$481.5M-$434.7M
Diluted EPS-$6.42-$5.57-$5.34-$3.91-$3.88
Operating cash flow-$935.0M-$683.9M-$536.2M-$400.4M-$363.3M
Cash and equivalents$510.4M$555.0M$482.4M$1.07B$716.8M
Total assets$2.26B$2.03B$1.33B$1.66B$1.24B
Total liabilities$1.53B$1.74B$1.66B$1.57B$833.0M
Shareholders' equity$739.0M$285.4M-$331.9M$88.0M$410.5M

As INSMED Inc tagged them in its 10-K filings: totals for the year on the income and cash-flow lines, values at the year's end on the balance-sheet lines. Latest 10-K, filed Feb 19, 2026 ↗

Stock Splits

Every split and reverse split in the price history
  • 1-for-10Reverse splitMar 3, 2011
  • 1-for-4Reverse splitJul 31, 2000

Split dates and ratios from the price history · Close Prices from Tiingo.com

Material Events (8-K)

Corporate events filed with the SEC
  • 8-K · Items 2.02, 9.01Results of operationsOct 29, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureOct 20, 2026
    EDGAR ↗
  • 8-K · Items 5.02, 7.01, 9.01Officer / director change · Reg FD disclosureOct 5, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsAug 6, 2026
    EDGAR ↗
  • 8-K · Items 7.01, 9.01Reg FD disclosureJul 16, 2026
    EDGAR ↗
  • 8-K · Items 5.07Shareholder voteMay 15, 2026
    EDGAR ↗
  • 8-K · Items 2.02, 9.01Results of operationsMay 7, 2026
    EDGAR ↗

About INSMED Inc

From SEC EDGAR company records
Industry (SIC 2834)Pharmaceutical Preparations
SectorHealthcare
HeadquartersBRIDGEWATER, NJ
IncorporatedVA